桑平
[摘要] 目的 探討經(jīng)皮椎體成型術(shù)治療椎體血管瘤的臨床治療效果。 方法 整群收集2010年1月—2014年12月在該創(chuàng)傷骨科行經(jīng)皮椎體成型術(shù)治療椎體血管瘤的36例患者作為觀察組,選取該院同期收治的實施傳統(tǒng)手術(shù)治療的36例患者作為對照組,對其治療效果進行總結(jié)分析。結(jié)果 觀察組臨床緩解率為94.4%,對照組臨床緩解率為75.0%,兩組比較差異有統(tǒng)計學(xué)意義(P<0.05)。 結(jié)論 經(jīng)皮椎體成型術(shù)治療椎體血管瘤可以明顯緩解患者的臨床癥狀,對身體的創(chuàng)傷小,安全系數(shù)較高,值得在臨床上推廣應(yīng)用。
[關(guān)鍵詞] 經(jīng)皮椎體成型術(shù);椎體血管瘤;療效
[中圖分類號] R687.3 [文獻標識碼] A [文章編號] 1674-0742(2015)09(b)-0081-02
[Abstract] Objective To explore the clinical effect of percutaneous vertebroplasty in treatment of vertebral hemangioma. Methods 36 patients who underwent percutaneous vertebroplasty for vertebral hemangioma in the Department of Trauma Orthopedics in our hospital between January 2010 and December 2014 were assigned to observation group, 36 cases of patients treated with traditional surgery in our department were selected as the control group,We summarized the efficacy of the two procedure performed in the two groups. Results The remission rate was 94.4% in the observation group and 75.0% in the control group, and the difference was statistically significant, P<0.05. Conclusion Percutaneous vertebroplasty for the treatment of vertebral hemangioma can obviously relieve the clinical symptoms with small trauma and high safety, therefore it is worthy of clinical application.
[Key words] Percutaneous vertebroplasty; Vertebral hemangioma; Effect
椎體血管瘤是臨床上比較常見的一種良性腫瘤,可發(fā)生于任何年齡,以40~60歲為多發(fā)年齡段,女性多于男性[1]。椎體血管瘤最常見的發(fā)病部位為胸椎下段(占60%)和腰椎上段(占29%),頸椎(占6%)和骶椎(占5%)次之[2]。椎體血管瘤會隨著年齡的增長和外界因素的刺激而增大,當(dāng)增大到一定程度時會對周圍的組織和神經(jīng)產(chǎn)生壓迫而出現(xiàn)臨床癥狀,如果不及時進行治療,會導(dǎo)致癱瘓的發(fā)生。經(jīng)皮椎體成型術(shù)是目前治療椎體血管瘤、骨髓瘤等的一線方法。為了進一步探討其療效,對該院2010年1月—2014年12月收治的36例椎體血管瘤患者進行經(jīng)皮椎體成型術(shù)治療,現(xiàn)報道如下。
1 資料與方法
1.1 一般資料
整群收集該院收治的經(jīng)皮椎體成型術(shù)治療椎體血管瘤的36例患者作為觀察組,其中男12例,女24例;年齡31~62歲,平均(46.4±2.1)歲;病程6個月~3年,平均(2.1±0.6)年;胸椎18例,腰椎10例,頸椎5例,骶椎3例。選取該院同期收治的經(jīng)傳統(tǒng)手術(shù)治療的36例患者作為對照組,其中男13例,女23例;年齡29~66歲,平均(47.5±2.4)歲;病程7個月~4.7年,平均(1.9±0.4)年;……